Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maruzen Pharmaceuticals is a Japanese company specializing in the research, development, and manufacture of plant-derived active ingredients for the pharmaceutical, cosmetic, and food industries. Founded in 1949 and headquartered in Hiroshima, the company is a global leader in the production of licorice-derived compounds, such as glycyrrhizin, which are utilized for their anti-inflammatory and hepatoprotective properties. Maruzen utilizes advanced extraction and purification technologies to identify and standardize bioactive molecules from a wide variety of botanical sources. Their business model includes the supply of high-quality raw materials as well as contract manufacturing services for global healthcare and personal care brands. The company is committed to the Science of Nature, focusing on evidence-based functional ingredients that support health and beauty. Maruzen operates multiple GMP-certified facilities and maintains a strong R&D focus on discovering new therapeutic applications for natural extracts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maruzen PCY.